Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture.
Cholangiopancreatography (prognosis)
Cholangitis (sclerosing)
Constriction (pathologic)
Contrast media
Magnetic resonance imaging (functional)
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
13 Jun 2024
13 Jun 2024
Historique:
received:
11
01
2024
accepted:
23
03
2024
revised:
20
03
2024
medline:
13
6
2024
pubmed:
13
6
2024
entrez:
13
6
2024
Statut:
aheadofprint
Résumé
Our aim was twofold. First, to validate Anali scores with and without gadolinium (ANALI This retrospective study included 123 patients with a mean age of 41.5 years, who underwent gadoxetic acid-enahnced MRI (GA-MRI). Five readers independently evaluated all images for calculation of ANALI Inter-reader agreement was almost perfect (ϰ = 0.81) for PFS, but only moderate-(ϰ = 0.55) for binary ANALI ANALI The combined use of Anali scores and the potential functional stricture (PFS), both derived from unenhanced-, and gadoxetic acid enhanced-MRI, could be applied as a diagnostic and prognostic imaging surrogate for counselling and monitoring primary sclerosing cholangitis patients. Primary sclerosing cholangitis patients require radiological monitoring to assess disease stability and for the presence and type of complications. A contrast-enhanced MRI algorithm based on potential functional stricture and ANALI scores risk-stratified these patients. Unenhanced ANALI score had a high negative predictive value, indicating some primary sclerosing cholangitis patients can undergo non-contrast MRI surveillance.
Identifiants
pubmed: 38869640
doi: 10.1007/s00330-024-10787-4
pii: 10.1007/s00330-024-10787-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Molodecky NA, Kareemi H, Parab R et al (2011) Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology 53:1590–1599
doi: 10.1002/hep.24247
Segal D, Marotta P, Mosli M, Zou G, Feagan BG, Al-Judaibi B (2019) The role of imaging in determining prognosis for primary sclerosing cholangitis: a systematic review. Saudi J Gastroenterol 25:152–158
doi: 10.4103/sjg.SJG_478_18
Silveira MG, Lindor KD (2008) Primary sclerosing cholangitis. Can J Gastroenterol 22:689–698
doi: 10.1155/2008/824168
Kim WR, Therneau TM, Wiesner RH et al (2000) A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 75:688–694
doi: 10.1016/S0025-6196(11)64614-4
Dave M, Elmunzer BJ, Dwamena BA, Higgins PD (2010) Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology 256:387–396
doi: 10.1148/radiol.10091953
Ruiz A, Lemoinne S, Carrat F, Corpechot C, Chazouillères O, Arrivé L (2014) Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology 59:242–250
doi: 10.1002/hep.26620
Lemoinne S, Cazzagon N, El Mouhadi S et al (2019) Simple magnetic resonance scores associate with outcomes of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 17:2785–2792.e3
doi: 10.1016/j.cgh.2019.03.013
Grave EC, Loehfelm T, Corwin MT et al (2024) Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitis. Abdom Radiol (NY) 49:60–68
Grigoriadis A, Ringe KI, Andersson M, Kartalis N, Bergquist A (2021) Assessment of prognostic value and interreader agreement of ANALI scores in patients with primary sclerosing cholangitis. Eur J Radiol 142:109884
doi: 10.1016/j.ejrad.2021.109884
Poetter-Lang S, Messner A, Bastati N et al (2023) Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study. Eur Radiol 33:9022–9037
Aabakken L, Karlsen TH, Albert J et al (2017) Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the study of the liver (EASL) clinical guideline. Endoscopy 49:588–608
doi: 10.1055/s-0043-107029
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871
doi: 10.1053/he.2000.5852
Sterling RK, Lissen E, Clumeck N et al (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43:1317–1325
doi: 10.1002/hep.21178
Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-Cárdenas E, Sánchez-Avila F, Vargas-Vorácková F (2008) AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol 7:350–357
doi: 10.1016/S1665-2681(19)31836-8
Johnson PJ, Berhane S, Kagebayashi C et al (2015) Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 33:550–558
doi: 10.1200/JCO.2014.57.9151
Goode EC, Clark AB, Mells GF et al (2019) Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system. Hepatology 69:2120–2135
doi: 10.1002/hep.30479
Boonstra K, Weersma RK, van Erpecum KJ et al (2013) Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58:2045–2055
doi: 10.1002/hep.26565
Goet JC, Floreani A, Verhelst X et al (2019) Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis. J Hepatol 71:992–999
doi: 10.1016/j.jhep.2019.06.012
Acar S, Akyildiz M (2019) A new prognostic model for primary sclerosing cholangitis. Turk J Gastroenterol 30:1004–1006
doi: 10.5152/tjg.2019.301019
Khoshpouri P, Ameli S, Ghasabeh MA et al (2018) Correlation between quantitative liver and spleen volumes and disease severity in primary sclerosing cholangitis as determined by Mayo risk score. Eur J Radiol 108:254–260
doi: 10.1016/j.ejrad.2018.10.006
Schulze J, Lenzen H, Hinrichs JB et al (2019) An imaging biomarker for assessing hepatic function in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 17:192–199.e3
doi: 10.1016/j.cgh.2018.05.011
Unalp-Arida A, Ruhl CE (2017) Liver fibrosis scores predict liver disease mortality in the United States population. Hepatology 66:84–95
doi: 10.1002/hep.29113
Beer L, Mandorfer M, Bastati N et al (2019) Inter- and intra-reader agreement for gadoxetic acid-enhanced MRI parameter readings in patients with chronic liver diseases. Eur Radiol 29:6600–6610
doi: 10.1007/s00330-019-06182-z
Fujita K, Nomura T, Morishita A et al (2019) Prediction of transplant-free survival through Albumin-Bilirubin score in primary biliary cholangitis. J Clin Med 8;1258.
de Vries EM, Wang J, Williamson KD et al (2018) A novel prognostic model for transplant-free survival in primary sclerosing cholangitis. Gut 67:1864–1869
doi: 10.1136/gutjnl-2016-313681
Hoeffel C, Azizi L, Lewin M et al (2006) Normal and pathologic features of the postoperative biliary tract at 3D MR cholangiopancreatography and MR imaging. Radiographics 26:1603–1620
doi: 10.1148/rg.266055730
Schramm C, Eaton J, Ringe KI, Venkatesh S, Yamamura J, MRI working group of the IPSCSG (2017) Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology 66:1675–1688
doi: 10.1002/hep.29293
Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N (1997) Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol 7:246–248
doi: 10.1007/s003300050145
Jung F, Cazzagon N, Vettorazzi E et al (2019) Rate of spleen length progression is a marker of outcome in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 17:2613–2615
doi: 10.1016/j.cgh.2018.12.033
Hartling L, Hamm M, Milne A et al (2012) In Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments. Rockville (MD)
Lindor KD, Kowdley KV, Harrison EM (2015) ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol 110:646–659. quiz 660
doi: 10.1038/ajg.2015.112
Ponsioen CY, Vrouenraets SM, Prawirodirdjo W et al (2002) Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 51:562–566
doi: 10.1136/gut.51.4.562
Rudolph G, Gotthardt D, Klöters-Plachky P, Kulaksiz H, Rost D, Stiehl A (2009) Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol 51:149–155
doi: 10.1016/j.jhep.2009.01.023
Hirschfield GM, Karlsen TH, Lindor KD, Adams DH (2013) Primary sclerosing cholangitis. Lancet 382:1587–1599
doi: 10.1016/S0140-6736(13)60096-3
Rupp C, Hippchen T, Bruckner T et al (2019) Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis. Gut 68:2170–2178
doi: 10.1136/gutjnl-2018-316801
Hammel P, Couvelard A, O'Toole D et al (2001) Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344:418–423
doi: 10.1056/NEJM200102083440604
Hilscher MB, Tabibian JH, Carey EJ, Gostout CJ, Lindor KD (2018) Dominant strictures in primary sclerosing cholangitis: a multicenter survey of clinical definitions and practices. Hepatol Commun 2:836–844
doi: 10.1002/hep4.1194